RotaFlash, June 2013

A new study published in the British Medical Journal provides the first post-licensure data on the real-world effectiveness of Rotarix® (a rotavirus vaccine) in a GAVI-eligible country. Bolivia was the first high-mortality country to introduce Rotarix® with GAVI support, has experienced an impressive public health impact on rotavirus-related hospitalizations due to the use of rotavirus vaccines.

Read the full article